50 
Monitoring Stem Cell Research 
"President Speaks at 30th Annual March for Life on the Mall," as made available by 
the White House Press Office, January 22, 2003. 
"Remarks by President George W. Bush on Stem Cell Research," as made available 
by the White House Press Office, August 9, 2001. 
"Remarks by the President upon Departure for New Jersey," as made available by 
the White House Press Office, August 23, 2000. 
National Institutes of Health, Report of the Human Embryo Research Panel, Be- 
thesda, MD: NIH, 1994. 
See, for instance, the "Moral Case for Cloning-for-Biomedical-Research" presented 
by some Members of the Council in the Council’s July 2002 report Human Cloning and 
Human Dignity: An Ethical Inquiry, chapter 6. 
Bush, G.W., "Stem Cell Science and the Preservation of Life," The New York Times, 
August 12, 2001, p. D13. 
See, for instance. Council discussion at its September 3, 2003, meeting. A transcript 
of that session is available on the Council’s website at www.bioethics.gov 
This question has been addressed by the Supreme Court on a number of occasions, 
in which the Court found that even activities protected as rights under the Constitu- 
tion are not thereby inherently worthy of financial support from the federal govern- 
ment. See, for instance, Maher v. Roe 432 U.S. 464 (1977); Harris v. McRae 448 U.S. 297 
(1980): and Rust v. Sullivan 500 U.S. 173 (1991). Also see Berkowitz, P. "The Meaning of 
Federal Funding, ’’ a paper commissioned by the Council and included in Appendix F 
of this report. 
The information provided in this section relies primarily on a presentation delivered 
before the Coimcil by NIH Director Elias Zerhouni on September 4, 2003, and on data 
otherwise made available by the National Institutes of Health. ’The full transcript of 
Director Zerhouni’s presentation may be found on the Council’s website at 
www.bioethics.gov. 
"Remarks by President George W. Bush on Stem Cell Research,” as made available 
by the White House Press Office, August 9, 2001. 
As of the autumn of 2003, the follovdng providers have eligible lines available for 
distribution: BresaGen (2 available lines), ES Cell International, Australia (5 available 
lines), MizMedi Hospital, South Korea (1 available line), Technion University, Israel (2 
available lines). University of California at San Francisco (1 availeible line), Wisconsin 
Alumni Research Foundation (1 available line). A complete list of available and eligible 
lines, updated as more lines become available, can be found at the NIH Stem Cell 
Registry website at stemcells.nih.gov. 
This information has been made available to the Coimcil by the National Institutes of 
Health. 
Quoted from a presentation before the Council by NIH Director Elias Zerhouni, 
September 4, 2003. ’The full transcript of Director Zerhouni’s presentation may be found 
on the Council’s website at www.bioethics.gov. 
PRE -PUBLICATION VERSION 
